SCHEMBL20189275

SCHEMBL20189275

COc1ccc(Br)cc1-n1c(N)nnc1-c1ccco1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APLNR P35414 5/20 0.62
ALDH1A1 P00352 8/20 0.44
HPGD P15428 7/20 0.44
KMT2A Q03164 6/20 0.44
MEN1 O00255 5/20 0.44
SIRT1 Q96EB6 3/20 0.44
LMNA P02545 2/20 0.44
MAPK1 P28482 2/20 0.44
KDM4C Q9H3R0 1/20 0.44
DCTPP1 Q9H773 1/20 0.44
NPC1 O15118 1/20 0.42
MAPT P10636 3/20 0.42
KDM4E B2RXH2 3/20 0.42
POLB P06746 3/20 0.42
HSD17B10 Q99714 2/20 0.42
ALOX15 P16050 1/20 0.42
TSHR P16473 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
F2 P00734 1/20 0.42
F12 P00748 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20190629 0.84 MEN1 (0.59) APLNRALDH1A1HPGDKMT2AMEN1
SCHEMBL20190224 0.78 APLNR (0.57) APLNRALDH1A1HPGDPOLBRECQL
SCHEMBL20190106 0.78 APLNR (0.52) APLNRALDH1A1HPGDNPC1MAPT
SCHEMBL20187769 0.77 APLNR (1.00) APLNRALDH1A1HPGDMAPK1DCTPP1
SCHEMBL20190250 0.75 APLNR (0.53) APLNRALDH1A1HPGDPOLBRECQL
SCHEMBL20190048 0.73 APLNR (0.61) APLNR
SCHEMBL20190589 0.71 APLNR (0.52) APLNRALDH1A1HPGDKMT2AMEN1
SCHEMBL20191039 0.70 APLNR (0.52) APLNRALDH1A1HPGDPOLBRECQL
SCHEMBL20168650 0.69 APLNR (0.56) APLNRALDH1A1HPGDKMT2AMEN1
SCHEMBL20191001 0.66 APLNR (0.44) APLNRALDH1A1HPGDSIRT1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3541792-B1 TRIAZOLE FURAN COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR AMGEN INC (US) 2020-12-23 EP disclosed
EP-3541792-B1 TRIAZOLE FURAN COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR AMGEN INC (US) 2020-12-23 EP disclosed
US-10736883-B2 Triazole furan compounds as agonists of the APJ receptor AMGEN INC. (US) 2020-08-11 US disclosed
US-10736883-B2 Triazole furan compounds as agonists of the APJ receptor AMGEN INC. (US) 2020-08-11 US disclosed
EP-3541792-A1 TRIAZOLE FURAN COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR Amgen Inc. (US) 2019-09-25 EP disclosed
US-20190275008-A1 TRIAZOLE FURAN COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR AMGEN INC. (US) 2019-09-12 US disclosed
US-20190275008-A1 TRIAZOLE FURAN COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR AMGEN INC. (US) 2019-09-12 US disclosed
WO-2018097944-A1 TRIAZOLE FURAN COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR AMGEN INC. (US) 2018-05-31 WO disclosed
WO-2018097944-A1 TRIAZOLE FURAN COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR AMGEN INC. (US) 2018-05-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190275008-A1 TRIAZOLE FURAN COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR TBXA2R, AGTR1, APLNR APLNR 3/4885ALDH1A1 1700/4885HPGD 1202/4885
US-10736883-B2 Triazole furan compounds as agonists of the APJ receptor TBXA2R, AGTR1, APLNR APLNR 3/4885ALDH1A1 1700/4885HPGD 1202/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.